KALARIS THERAPEUTICS INC (KLRS) Stock Cash Flow
NASDAQ:KLRS - Nasdaq - US4829291065 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.67M | -58.77M | -190.42M | -168.71M | -171.96M | |||
| Depreciation Amortization | N/A | N/A | 398.00K | 720.00K | 190.00K | |||
| Change In Working Capital | -9.96M | -25.30M | 2.02M | -16.15M | 19.35M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 0.00 | 220.00K | N/A | N/A | |||
| Other non cash items | 17.99M | 16.37M | 63.54M | 42.08M | 46.10M | |||
| OPERATING CASH FLOW | -31.15M | -67.70M | -124.45M | -142.05M | -106.32M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -30.00K | |||
| Other Investing Activity | N/A | 95.00M | 37.98M | -80.48M | 186.01M | |||
| INVESTING CASH FLOW | N/A | 95.00M | 37.98M | -80.48M | 185.98M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | N/A | 21.00K | 70.50M | 126.96M | 230.00K | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | N/A | 21.00K | 70.50M | 126.96M | 230.00K | |||
| Exchange Rate Effect | N/A | N/A | N/A | 0.00 | -40.00K | |||
| CHANGE IN CASH | 131.52M | 27.32M | -15.97M | -95.57M | 79.85M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -31.15M | -67.70M | -124.45M | -142.05M | -106.32M | |||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -30.00K | |||
| FREE CASH FLOW | -31.15M | -67.70M | -124.45M | -142.05M | -106.35M | |||
All data in USD